Tag: Janssen Pharmaceuticals

Risperdal Punitive Damages

Risperdal Off-Label Prescriptions May Expose Johnson & Johnson to Punitive Damages

Plaintiffs in consolidated Risperdal lawsuits now pending in Pennsylvania have argued that a New Jersey statute barring punitive damages in lawsuits brought involving FDA-approved drugs does not apply when the injuries alleged result from off-label or[...]

Risperdal Lawsuit Bars Claims for Punitive Damages

Risperdal Lawsuits Time Barred, Argues Johnson & Johnson

Janssen Pharmaceuticals, a division of Johnson & Johnson  that manufactured and marketed the antipsychotic drug Risperdal to adolescent males, asked a Pennsylvania court in a Motion for Summary Judgment dated May 19, 2014, to hold that[...]